Heartseed and Novo Nordisk announce first patient dosed in clinical study with HS-001 a cell therapy designed to restore heart function in people with advanced heart failure  Yahoo Finance

See the article here:

Heartseed and Novo Nordisk announce first patient dosed in clinical study with HS-001 a cell therapy designed to restore heart function in people...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh